CD19 and acute myeloid leukemia: Two of these patients developed acute myeloid leukemia (AML) relapse and loss of B lymphoid lineage antigens, including CD19, within 1 month, demonstrating that CD19 CAR T-cells could induce myeloid conversion in ALL.